tiprankstipranks
Trending News
More News >
Cabaletta Bio (CABA)
NASDAQ:CABA
US Market

Cabaletta Bio (CABA) Financial Statements

Compare
1,418 Followers

Cabaletta Bio Financial Overview

Cabaletta Bio's market cap is currently $210.82M. The company's EPS TTM is $-0.44; its P/E ratio is -1.16; Cabaletta Bio is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.46. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -4.81M$ -1.43M$ -3.68M$ -733.00K$ -354.00K
Operating Income$ -125.14M$ -74.66M$ -54.14M$ -46.31M$ -33.83M
EBITDA$ -110.30M$ -66.25M$ -49.29M$ -45.56M$ -32.98M
Net Income$ -115.86M$ -67.67M$ -52.98M$ -46.29M$ -33.34M
Balance Sheet
Cash & Short-Term Investments$ 163.96M$ 241.25M$ 106.55M$ 122.22M$ 108.66M
Total Assets$ 185.05M$ 253.65M$ 116.97M$ 126.34M$ 114.72M
Total Debt$ 15.60M$ 5.02M$ 5.14M$ 0.00$ 0.00
Net Debt$ -148.36M$ -188.22M$ -76.47M$ -122.22M$ -101.43M
Total Liabilities$ 32.71M$ 17.45M$ 12.45M$ 8.38M$ 5.18M
Stockholders' Equity$ 152.34M$ 236.20M$ 104.52M$ 117.96M$ 109.54M
Cash Flow
Free Cash Flow$ -90.43M$ -54.24M$ -48.83M$ -35.27M$ -27.41M
Operating Cash Flow$ -88.22M$ -53.55M$ -46.38M$ -34.11M$ -26.77M
Investing Cash Flow$ 47.29M$ -22.45M$ -27.22M$ 6.00M$ -7.98M
Financing Cash Flow$ 11.68M$ 187.63M$ 32.98M$ 48.90M$ -24.00K
Currency in USD

Cabaletta Bio Earnings and Revenue History

Cabaletta Bio Debt to Assets

Cabaletta Bio Cash Flow

Cabaletta Bio Forecast EPS vs Actual EPS